England’s NICE Defends Its Processes, But Recognizes ‘Tough’ Climate For Industry

Lawrence Tallon, MHRA CEO and Sam Roberts, NICE CEO, in London, UK, 2025 (Pink Sheet)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Health Technology Assessment

More from United Kingdom